Assessment of the Feasibility of a Systematic Multidimensional Evaluation of the Outcome of Traumatic Brain Injury Patients and Their Relatives.
NCT ID: NCT06194071
Last Updated: 2024-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2023-11-11
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Self-defining Memories in Patients With a TBI
NCT02680210
Functional Connectivity Measurement After Severe Traumatic Brain Injury
NCT02647996
Efficacy of Multidimensional Management of Mild Traumatic Brain Injury
NCT03811626
Assessment and Rehabilitation of Social Cognition in People With Traumatic Brain Injury
NCT04562844
Evaluating the Effectiveness of Treatment for Metacognition in Moderate and Severe Traumatic Brain Injury
NCT03169647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Traumatic Brain Injury
Patients with all types of TBI will be recruited (mild, moderate and severe). They mus accept participation in the prolonged follow-up (up to 18 months after the accident). Relatives will also accept to participate. Patients will undergo routine care regarding TBI in our institution. Only the prolonged follow-up and monitoring is proposed which combines remote questionnaire completion, and on-site visits at 3 time-points (6, 12 and 18 months). No on-site visit is proposed for relatives who will fill out questionnaires. However, they may accompany patients during on-sites visits.
Completion of questionnaires and on-site visits during an 18 months follow-up after TBI
We will evaluate the same outcomes and use the same questionnaires at 6, 12 and 18 months post-TBI.
For patients we will evaluate:
* Functional Outcome (GOS-Extended)
* Health-related Quality of Life (QOLIBRI)
* Neurocognitive tests (MoCA)
* Independence (Barthel Index)
* Daily issues (BICOQ)
* Anxiety and depression symptoms (HADS)
* Medico-economic evaluation (EQ5D-5L)
For Relatives we will evaluate:
* Symptoms of anxiety and depression (HADS)
* The appreciation of the patient's daily issues from their point of view (dedicated Bicoq for relatives)
* Burden of care (ZARIT)
Throughout the follow-up we will nest a qualitative research programs which will focus on several aspects:
* feasibility of such follow-up (6 months is the primary endpoint) defined as the drop-out rate, complete or incomplete completion of scales and their reasons
* factors that may lead to drop-out or the contrary that solidifies the follow-up
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Completion of questionnaires and on-site visits during an 18 months follow-up after TBI
We will evaluate the same outcomes and use the same questionnaires at 6, 12 and 18 months post-TBI.
For patients we will evaluate:
* Functional Outcome (GOS-Extended)
* Health-related Quality of Life (QOLIBRI)
* Neurocognitive tests (MoCA)
* Independence (Barthel Index)
* Daily issues (BICOQ)
* Anxiety and depression symptoms (HADS)
* Medico-economic evaluation (EQ5D-5L)
For Relatives we will evaluate:
* Symptoms of anxiety and depression (HADS)
* The appreciation of the patient's daily issues from their point of view (dedicated Bicoq for relatives)
* Burden of care (ZARIT)
Throughout the follow-up we will nest a qualitative research programs which will focus on several aspects:
* feasibility of such follow-up (6 months is the primary endpoint) defined as the drop-out rate, complete or incomplete completion of scales and their reasons
* factors that may lead to drop-out or the contrary that solidifies the follow-up
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients admitted to ER with Glasgow score during initial care ≤ 15 or concussion and CT-confirmed head injury or displaying clinicalsigns such as headaches or vomiting.
Exclusion Criteria
* Single patient, without relative or informal caregiver
* Non-French-speaking patient
* Refusal of consent
* Patient under guardianship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nantes
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AR_2023_002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.